N-Acetyl-D-Glucosamine CAS:7512-17-6 Manufacturer Supplier
N-Acetyl-D-glucosamine is used in the identification and characterization of N-acetyl-beta-D-hexoaminidase. It is also used in the treatment of osteoarthritis and inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. Further, it is used as a substrate in sialic acid production, cosmetics and in drug development research.N-acetyl-D-Glucosamine (GlcNAc) is a monosaccharide derivative of glucose. It is released by the action of O-GlcNAcase, in mammalian systems from proteins that have been post-translationally modified with O-GlcNAc. Levels of O-GlcNAcylation proteins from Alzheimer’s disease brain extracts are decreased as compared to that in controls, suggesting that release of GlcNAc may contribute to pathogenesis.
Composition | C8H15NO6 |
Assay | 99% |
Appearance | White to off-white powder |
CAS No. | 7512-17-6 |
Packing | 25KG |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |